evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/geneAliases/4,gene/geneAliases/5,gene/geneAliases/6,gene/geneAliases/7,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract
19744,GENE_BACKGROUND,,"The CTLA4 (cytotoxic T-lymphocyte–associated antigen-4) gene encodes a transmembrane immunoglobulin receptor that blocks activation of T-lymphocytes (PMID: 9653097). CTLA4 binds to ligand B7-1 and B7-2, present on antigen presenting cells (PMID: 7543139). Binding of these ligands prevents their binding to CD28, the co-stimulatory molecule on T-cells, and also transduces an inhibitory signal within the T-cell (PMID: 11244047). Inhibition of CTLA4 has been employed in immune therapy of cancer by allowing activation of tumor specific T-cells (PMID: 20525992). Inherited mutations in CTLA4 lead to immune dysregulation, hyper-activated T-cells and loss of normal circulating B-cells (PMID: 25213377). Polymorphisms and mutations in CTLA4 are associated with autoimmune disease (PMID: 25695113, 25329329).",,2017-03-01,,1493,CTLA4,cytotoxic T-lymphocyte associated protein 4,True,ENST00000302823,NM_005214.4,ALPS5,CD,CD152,CELIAC3,IDDM12,GSE,CTLA-4,GRD4,False,9653097,B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28.,The Journal of experimental medicine,0001-07-06,188,True,205-10,Fallarino F et al,,,0001-07-06,,7543139,CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.,The Journal of experimental medicine,0001-08-01,182,2,459-65,Krummel MF et al,,,0001-08-01,,11244047,CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy.,Annual review of immunology,2001,19,,565-94,Chambers CA et al,,,Chambers CA et al. Annual review of immunology. 2001;19()565-94.,,25213377,Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4.,"Science (New York, N.Y.)",2018-09-26T20:14:00,345,6204,1623-1627,Kuehn HS et al,doi: 10.1126/science.1255904,,2018-09-26T16:27:00,,20525992,Improved survival with ipilimumab in patients with metastatic melanoma.,The New England journal of medicine,2018-08-19T20:10:00,363,8,711-23,Hodi FS et al,doi: 10.1056/NEJMoa1003466,,0001-08-19,,25695113,Allelic variant in CTLA4 is associated with thyroid failure   and faster β-cell exhaustion in latent autoimmune   diabetes in adults.,Journal of diabetes,2018-01-01T20:15:00,7,True,68-73,Delitala AP et al,,,0001-01-01,,25329329,Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations.,Nature medicine,2017-12-01T20:14:00,20,12,1410-1416,Schubert D et al,doi: 10.1038/nm.3746,,2017-12-01T14:16:00,
19743,GENE_SUMMARY,,"CTLA4 encodes a transmembrane immunoglobulin receptor that delivers inhibitory signals within T cells. Inhibition of CTLA4 has been employed in immune therapy in cancer, while mutations in CTLA4 have mainly been associated with autoimmune diseases.",,2017-03-01,,1493,CTLA4,cytotoxic T-lymphocyte associated protein 4,True,ENST00000302823,NM_005214.4,ALPS5,CD,CD152,CELIAC3,IDDM12,GSE,CTLA-4,GRD4,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
